Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
31 studies found for:    "nonbullous congenital ichthyosiform erythroderma" OR "Congenital Ichthyosiform Erythrodermas" OR "Congenital Ichthyosiform Erythroderma" OR "Ichthyosiform Erythroderma, Congenital" OR "Ichthyosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
Condition: Congenital Ichthyosis
Interventions: Drug: PAT-001, 0.1%;   Drug: PAT-001, 0.2%;   Drug: Vehicle
2 Unknown  Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous
Condition: Lamellar Ichthyosis
Intervention: Drug: apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side
3 Recruiting A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis
Condition: Ichthyosis
Intervention: Other: Observation
4 Completed Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis
Condition: Ichthyosis
Intervention: Drug: monolaurin cream
5 Completed Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis
Condition: Ichthyosis, Lamellar
Intervention: Drug: Liarozole
6 Enrolling by invitation Comparison of Different Concentrations of Carbamide as Moisturizers in Ichthyosis Vulgaris
Condition: Ichthyosis Vulgaris
Interventions: Other: Comparing the effect of moisturizers with 5 and 7.5 % carbamide, respectively;   Other: Comparing the effect of moisturizers with 5 and 10 % carbamide, respectively;   Other: Comparing the effect of moisturizers with 7.5 and 10 % carbamide, respectively
7 Recruiting The Efficacy and Safety of Secukinumab in Patients With Ichthyoses
Conditions: Ichthyosis;   Autosomal Recessive Congenital Ichthyosis;   Lamellar Ichthyosis;   Congenital Ichthyosiform Erythroderma;   Epidermolytic Ichthyosis;   Netherton Syndrome
Interventions: Drug: Secukinumab;   Drug: Placebo
8 Completed
Has Results
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Conditions: Atopic Dermatitis;   Ichthyosis Vulgaris
Intervention: Genetic: Buccal Swab
9 Withdrawn Novel Treatment for Syndromic Ichthyoses
Conditions: Syndromic Ichthyoses;   CHILD Syndrome;   Smith Lemli Opitz Syndrome;   Conradi Syndrome
Intervention: Drug: Lovastatin
10 Completed Study of Scaling Disorders and Other Inherited Skin Diseases
Conditions: Genetic Skin Disease;   Keratosis Follicularis;   Lamellar Ichthyosis
Intervention:
11 Completed A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)
Condition: Sjögren-Larsson Syndrome
Interventions: Drug: Active topical NS2 1% dermatologic cream;   Drug: Vehicle placebo 0.0% NS2 dermatologic cream
12 Unknown  National Registry for Ichthyosis and Related Disorders
Conditions: Darier Disease;   Hailey-Hailey Disease;   Hyperkeratosis, Epidermolytic;   Ichthyosis;   Ichthyosis, Lamellar;   Ichthyosis, X-Linked;   Keratoderma
Intervention:
13 Recruiting Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Conditions: Atopic Dermatitis;   Eczema;   Ichthyosis Vulgaris
Intervention:
14 Recruiting Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments
Conditions: Atopic Dermatitis;   Ichthyosis;   Psoriasis
Interventions: Other: Itch Questionnaire and Interview;   Other: Stigma Questionnaire and Interview
15 Unknown  Xeroderma Pigmentosum Patient Experiences
Condition: Xeroderma Pigmentosum
Intervention: Other: Survey Study
16 Recruiting International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
Condition: Neutral Lipid Storage Disease
Intervention:
17 Recruiting Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
Conditions: Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV);   Neutral Lipid Storage Disease With Myopathy (NLSD-M)
Intervention: Dietary Supplement: CNT-02
18 Completed The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)
Condition: Neutral Lipid Storage Disease
Intervention: Drug: Fibrate treatment
19 Completed Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing
Conditions: Pressure Ulcers;   Venous Ulcers;   Diabetic Ulcers;   Chronic Ulcer of Foot;   Trauma-related Wound
Intervention: Device: Marigen Wound Dressing
20 Recruiting Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
Conditions: Metabolism, Inborn Errors;   Lipid Metabolism, Inborn Errors;   Carbohydrate Metabolism, Inborn Errors;   Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency;   Glycogenin-1 Deficiency (Glycogen Storage Disease Type XV);   Carnitine Palmitoyl Transferase 2 Deficiency;   VLCAD Deficiency;   Medium-chain Acyl-CoA Dehydrogenase Deficiency;   Multiple Acyl-CoA Dehydrogenase Deficiency;   Carnitine Transporter Deficiency;   Neutral Lipid Storage Disease;   Glycogen Storage Disease Type II;   Glycogen Storage Disease Type III;   Glycogen Storage Disease Type IV;   Glycogen Storage Disease Type V;   Muscle Phosphofructokinase Deficiency;   Phosphoglucomutase 1 Deficiency;   Phosphoglycerate Mutase Deficiency;   Phosphoglycerate Kinase Deficiency;   Phosphorylase Kinase Deficiency;   Beta Enolase Deficiency;   Lactate Dehydrogenase Deficiency;   Glycogen Synthase Deficiency
Intervention: Other: Sugar

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.